The MiniMed 670g monitors the user's blood glucose levels on a small device that fits around the waistband. This device then can sense a rise in sugar levels triggering automatic delivery of insulin to regulate the patient's system, according to Newsweek. Users can choose to be alerted to the injection, or they can simply trust the device to do its job.
Aside from the glucose sensor attached to the patient, there is also an insulin pump patch that is able to inject highly specific amounts of insulin doses to each patient per the machine's input. As trials have begun for the use of the device, patients are loving the autonomy it presents back into their lives along with the lack of worry about subsequent hypoglycemic attacks.
Less than 30% of adults with Type 1 diabetes are able to maintain their blood sugar levels on their own, according to Bloomberg, which is what makes this device so necessary. Medtronic has tested the device with 124 patients over the course of 6 months seeing no adverse side effects and the technology working according to specifications. Completion of this testing has now led the company to submit applications for approval from the FDA, and it hopefully will be coming soon.
We are also on Face Book, Click on Like to jois us
FB Page: https://www.facebook.com/pages/Hyderabad-Masti/335077553211328
FB Group: https://www.facebook.com/groups/hydmasti/
You received this message because you are subscribed to the Google Groups "Hyderabad Masti" group.
To unsubscribe from this group and stop receiving emails from it, send an email to email@example.com.
For more options, visit https://groups.google.com/d/optout.